Key Financial Data Of Reporting Company

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7256444

Concept	As at 2025-03-31	As at 2025-03-31	2024-04-01 to 2025-03-31	As at 2025-03-31	As at 2025-03-31	As at 2025-03-31	As at 2025-03-31	As at 2024-03-31	2023-04-01 to 2024-03-31	As at 2023-03-31	2022-04-01 to 2023-03-31	2021-04-01 to 2022-03-31	As at 2022-03-31	As at 2021-03-31	2020-04-01 to 2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales	—	—	7,789,462,000 JPY	—	—	—	—	—	7,738,426,000 JPY	—	8,660,379,000 JPY	8,383,145,000 JPY	—	—	8,895,838,000 JPY
Ordinary profit (loss)	—	—	-409,238,000 JPY	—	—	—	—	—	-161,857,000 JPY	—	242,574,000 JPY	72,259,000 JPY	—	—	-604,961,000 JPY
Profit (loss)	—	—	64,440,000 JPY	—	—	—	—	—	108,959,000 JPY	—	138,256,000 JPY	238,543,000 JPY	—	—	-601,856,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied	—	—	JPY	—	—	—	—	—	JPY	—	JPY	JPY	—	—	JPY
Share capital	—	—	—	—	3,395,887,000 JPY	—	—	3,395,887,000 JPY	—	3,395,887,000 JPY	—	—	3,395,887,000 JPY	3,395,887,000 JPY	—
Total number of issued shares	—	—	—	—	34,838,000 xbrli:shares	—	—	34,838,000 xbrli:shares	—	34,838,000 xbrli:shares	—	—	34,838,000 xbrli:shares	34,838,000 xbrli:shares	—
Net assets	—	—	—	—	11,610,351,000 JPY	—	—	12,026,073,000 JPY	—	11,906,669,000 JPY	—	—	11,480,803,000 JPY	11,385,570,000 JPY	—
Total assets	—	—	—	—	15,002,709,000 JPY	—	—	15,421,054,000 JPY	—	15,711,553,000 JPY	—	—	14,953,435,000 JPY	14,572,472,000 JPY	—
Net assets per share	—	—	—	—	334.53	—	—	346.50	—	343.06	—	—	330.79	328.04	—
Dividend paid per share	—	—	3.00	—	—	—	—	—	3.00	—	3.00	0.00	—	—	0.00
Interim dividend paid per share	—	—		—	—	—	—	—		—			—	—
Basic earnings (loss) per share	—	—	1.85	—	—	—	—	—	3.13	—	3.98	6.87	—	—	-17.34
Diluted earnings per share	—	—		—	—	—	—	—		—			—	—
Equity-to-asset ratio	—	—	—	—	0.7739 xbrli:pure	—	—	0.7798 xbrli:pure	—	0.7578 xbrli:pure	—	—	0.7677 xbrli:pure	0.7813 xbrli:pure	—
Rate of return on equity	—	—	0.0055 xbrli:pure	—	—	—	—	—	0.0091 xbrli:pure	—	0.0118 xbrli:pure	0.0209 xbrli:pure	—	—	-0.0516 xbrli:pure
Price-earnings ratio	—	—	171.35 xbrli:pure	—	—	—	—	—	72.52 xbrli:pure	—	62.06 xbrli:pure	42.06 xbrli:pure	—	—	xbrli:pure
Payout ratio	—	—	1.6216 xbrli:pure	—	—	—	—	—	0.9585 xbrli:pure	—	0.7500 xbrli:pure	xbrli:pure	—	—	xbrli:pure
Net cash provided by (used in) operating activities	—	—	-592,454,000 JPY	—	—	—	—	—	-107,338,000 JPY	—	631,920,000 JPY	339,174,000 JPY	—	—	163,438,000 JPY
Net cash provided by (used in) investing activities	—	—	-13,498,000 JPY	—	—	—	—	—	-2,352,000 JPY	—	17,131,000 JPY	50,572,000 JPY	—	—	-199,513,000 JPY
Net cash provided by (used in) financing activities	—	—	-103,935,000 JPY	—	—	—	—	—	-104,986,000 JPY	—	-1,615,000 JPY	-1,620,000 JPY	—	—	-3,829,000 JPY
Cash and cash equivalents	—	—	—	—	2,954,759,000 JPY	—	—	3,664,647,000 JPY	—	3,879,325,000 JPY	—	—	3,231,889,000 JPY	2,843,762,000 JPY	—
Number of employees	xbrli:pure	15 xbrli:pure	—	167 xbrli:pure	286 xbrli:pure	6 xbrli:pure	98 xbrli:pure	274 xbrli:pure	—	292 xbrli:pure	—	—	300 xbrli:pure	306 xbrli:pure	—
Average number of temporary employees	xbrli:pure	5 xbrli:pure	—	79 xbrli:pure	118 xbrli:pure	3 xbrli:pure	31 xbrli:pure	100 xbrli:pure	—	90 xbrli:pure	—	—	87 xbrli:pure	100 xbrli:pure	—
Total shareholder return	—	—	—	—	1.417 xbrli:pure	—	—	1.013 xbrli:pure	—	1.087 xbrli:pure	—	—	1.257 xbrli:pure	1.861 xbrli:pure	—
Total return on share price index	—	—	—	—	2.134 xbrli:pure	—	—	2.168 xbrli:pure	—	1.534 xbrli:pure	—	—	1.450 xbrli:pure	1.421 xbrli:pure	—